MBS Pharma

MBS Pharma is a Sweden-based private pharmaceutical company that advances drug discovery and development projects through a virtual operating model using external partnerships and CROs. The company appears to focus on early-stage small-molecule programs, including projects aimed at targets involved in interferon biology and regulatory T cell biology. In addition to its internal pipeline, MBS Pharma offers consulting services to life science companies in areas such as project and portfolio review, therapeutic indication strategy, business planning, and CMC-related support. Publicly available information suggests it is a lean organization centered on outsourced R&D execution rather than large in-house infrastructure.